Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.

Columbus Regional Health Heart & Vascular announced that its cardiovascular services team recently completed its 100th ...

Registry analysis suggests endoscopic lung volume reduction yields similar physiologic gains across sexes, but women report ...

Abbott will soon enter the competitive U.S. pulsed field ablation (PFA) market, having just received FDA approval for its ...

BMY has agreed to supply Eliquis free of charge to Medicaid starting in 2026 and will also donate seven tons of the active pharmaceutical ingredient used in Eliquis.

Abbott Laboratories is set to roll out its Volt PFA System in the U.S., following federal approval, and continue expanding ...

Boston Scientific Corporation is rated a Hold with double-digit revenue growth and margin expansion. Learn more about BSX ...

MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM ...

Introduction Atrial fibrillation (AF) is the leading cause of cardioembolic stroke and is associated with increased stroke severity and fatality. Early identification of AF is essential for adequate ...

No one can predict what the medical device industry will look like in 2026. Still, the events of 2025 provide meaningful ...

Bristol Myers Squibb Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans ...

A new form of technology that is designed to improve heart function through a tool that provides a transcatheter edge-to-edge ...